Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BBLG will decline by -2.70% over the next 2 Weeks and hit $1.24 by Friday, May 29, 2026. In that time frame, BBLG's share price is expected to range between $1.19 and $1.28.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 29, 2026 | 1.18 | 1.23 | 1.28 |
| May 28, 2026 | 1.17 | 1.22 | 1.26 |
| May 27, 2026 | 1.18 | 1.23 | 1.28 |
| May 26, 2026 | 1.18 | 1.22 | 1.27 |
| May 25, 2026 | 1.18 | 1.23 | 1.27 |
| May 22, 2026 | 1.20 | 1.25 | 1.30 |
| May 21, 2026 | 1.19 | 1.24 | 1.28 |
| May 20, 2026 | 1.21 | 1.25 | 1.30 |
| May 19, 2026 | 1.19 | 1.24 | 1.29 |
| May 18, 2026 | 1.20 | 1.25 | 1.29 |
BBLG shares remained flat 0 in Friday, May 15, 2026's trading session, starting and closing at a previous close of $1.27 to move at $1.27. The stock demonstrated notable intraday movement (see BBLG's key stats for a full breakdown), fluctuating between $1.27 and $1.29, a +1.69% trading range. While recent weeks have seen some volatility, BBLG has managed to secure a -5.22% drop over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 12.28K shares changing hands, 1.2K fewer than the previous session. This amounted to $15.59K in total market activity.
Will BBLG Continue Its Upward Trend?
According to analyst ratings and projections for BBLG, Bone Biologics Corporation shares are anticipated to increase by +0.68%, potentially reaching $1.28 per share by May 29, 2026. Short-term technical indicators currently suggest a neutral sentiment for BBLG. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the BBLG stock forecast, now is a good time to buy BBLG stock because its current trading price is +3.34% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BBLG covering social and institutional perspectives.
BBLG Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BBLG's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 41.73% to 47.26%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.40%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.00%, maintains a neutral outlook for the long term. Insights into BBLG's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Bone Biologics Short-Term Forecasts
BBLG Forecast For Next 5 Days
Our algorithm anticipates Bone Biologics (BBLG) stock could hit $1.32 by May 22, 2026. This represents a +3.71% rise from today's price, following a +4.85% change over the past five days.
BBLG Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Bone Biologics Corporation (BBLG) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $1.30, which would mean a +2.36% increase from the current price of $1.27. Projections for this period range from a high of $1.42 to a low of $1.11.
BBLG Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Bone Biologics's price over the next three months point to a drop. BBLG stock is expected to peak at $2.81 on May 27, 2026 before potentially dipping to $0.00 on Aug 17, 2026. On average, BBLG is likely to trade around $0.99 in the coming 90 days.
Bone Biologics Stock Forecast 2025
Based on our predictive models, Bone Biologics (BBLG) is expected to trade between $0.00 and $2.81 throughout 2026. This would result in an average price of $0.79, potentially offering investors a -37.80% return from current levels.
Bone Biologics Corporation Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Bone Biologics Corporation (BBLG) is positioned to show a strong performance in May 2026. The price is predicted to move between $0.00 and $2.81, settling at an average of $1.27. This could translate to a 0 gain.
June 2026
Based on current market signals, Bone Biologics Corporation is projected to trend june 2026. We forecast a trading range from $0.00 to $2.56, with a likely average price of $1.03. Investors could expect a potential return of -18.90%.
July 2026
Our predictive algorithms indicate Bone Biologics Corporation stock may see a shift in July 2026. The expected range spans $0.00–$2.44, with an average target of $0.82. This represents a cautious outlook and a possible loss of -35.43%.
August 2026
Analyzing established trends, Bone Biologics Corporation looks set to move in August 2026. Projections place the stock between $0.00 and $2.33, averaging around $0.86. This suggests a -32.28% loss from current levels.
September 2026
Market indicators suggest Bone Biologics Corporation could experience notable changes during September 2026. Prices could fluctuate within $0.00 to $2.06, with a midpoint forecast of $0.68. The stock might deliver a -46.46% loss.
October 2026
Forecasting for October 2026, models estimate that Bone Biologics Corporation may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.10, averaging $0.73. This signals a cautious trajectory with potential returns around -42.52%.
November 2026
According to our latest forecast models, Bone Biologics Corporation (BBLG) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $2.10, settling at an average of $0.65. This could translate to a -48.82% loss.
December 2026
Based on current market signals, Bone Biologics Corporation is projected to trend december 2026. We forecast a trading range from $0.00 to $1.97, with a likely average price of $0.55. Investors could expect a potential return of -56.69%.
January 2027
Our predictive algorithms indicate Bone Biologics Corporation stock may see a shift in January 2027. The expected range spans $0.00–$2.19, with an average target of $0.64. This represents a cautious outlook and a possible loss of -49.61%.
February 2027
Analyzing established trends, Bone Biologics Corporation looks set to move in February 2027. Projections place the stock between $0.00 and $1.86, averaging around $0.50. This suggests a -60.63% loss from current levels.
March 2027
Market indicators suggest Bone Biologics Corporation could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $1.81, with a midpoint forecast of $0.41. The stock might deliver a -67.72% loss.
April 2027
Forecasting for April 2027, models estimate that Bone Biologics Corporation may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.74, averaging $0.34. This signals a cautious trajectory with potential returns around -73.23%.
May 2027
According to our latest forecast models, Bone Biologics Corporation (BBLG) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $1.58, settling at an average of $0.30. This could translate to a -76.38% loss.
BBLG's history of dividends and stock splits also plays a role in long-term investor confidence.

